يعرض 1 - 10 نتائج من 27 نتيجة بحث عن '"Cowey C. L."', وقت الاستعلام: 1.52s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Adjuvant nivolumab versus ipilimumab (CheckMate 238 trial): Reassessment of 4-year efficacy outcomes in patients with stage III melanoma per AJCC-8 staging criteria

    المؤلفون: Larkin J., Weber J., Del Vecchio M., Gogas H., Arance A. M., Dalle S., Cowey C. L., Schenker M., Grob J. -J., Chiarion-Sileni V., Marquez-Rodas I., Butler M. O., Di Giacomo A. M., Middleton M. R., De la Cruz-Merino L., Arenberger P., Atkinson V., Hill A., Fecher L. A., Millward M., Khushalani N. I., Queirolo P., Long G. V., Lobo M., Askelson M., Ascierto P. A., Mandala M.

    المساهمون: Larkin, J., Weber, J., Del Vecchio, M., Gogas, H., Arance, A. M., Dalle, S., Cowey, C. L., Schenker, M., Grob, J. -J., Chiarion-Sileni, V., Marquez-Rodas, I., Butler, M. O., Di Giacomo, A. M., Middleton, M. R., De la Cruz-Merino, L., Arenberger, P., Atkinson, V., Hill, A., Fecher, L. A., Millward, M., Khushalani, N. I., Queirolo, P., Long, G. V., Lobo, M., Askelson, M., Ascierto, P. A., Mandala, M.

    مصطلحات موضوعية: AJCC-8 criteria, Distant metastase, Ipilimumab, Melanoma adjuvant therapy, Nivolumab, Recurrence-free survival, Stage 3, Adjuvants, Immunologic, Human, Neoplasm Staging, Melanoma, Skin Neoplasms

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35964471; info:eu-repo/semantics/altIdentifier/wos/WOS:000922633300002; volume:173; firstpage:285; lastpage:296; numberofpages:12; journal:EUROPEAN JOURNAL OF CANCER; https://hdl.handle.net/11365/1221042Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85135858543; https://www.sciencedirect.com/science/article/pii/S0959804922003926Test

    الإتاحة: https://doi.org/10.1016/j.ejca.2022.06.041Test
    https://hdl.handle.net/11365/1221042Test
    https://www.sciencedirect.com/science/article/pii/S0959804922003926Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Adjuvant nivolumab for stage III/IV melanoma: Evaluation of safety outcomes and association with recurrence-free survival

    المؤلفون: Mandala M., Larkin J., Ascierto P. A., Del Vecchio M., Gogas H., Cowey C. L., Arance A., Dalle S., Schenker M., Grob J. -J., Chiarion-Sileni V., Marquez I., Butler M. O., Di Giacomo A. M., Lutzky J., De La Cruz-Merino L., Atkinson V., Arenberger P., Hill A., Fecher L., Millward M., Khushalani N. I., De Pril V., Lobo M., Weber J.

    المساهمون: Mandala, M., Larkin, J., Ascierto, P. A., Del Vecchio, M., Gogas, H., Cowey, C. L., Arance, A., Dalle, S., Schenker, M., Grob, J. -J., Chiarion-Sileni, V., Marquez, I., Butler, M. O., Di Giacomo, A. M., Lutzky, J., De La Cruz-Merino, L., Atkinson, V., Arenberger, P., Hill, A., Fecher, L., Millward, M., Khushalani, N. I., De Pril, V., Lobo, M., Weber, J.

    مصطلحات موضوعية: adjuvant, immunologic, immunotherapy, melanoma, programmed cell death 1 receptor

    وصف الملف: ELETTRONICO

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34452930; info:eu-repo/semantics/altIdentifier/wos/WOS:000691920700003; volume:9; issue:8; firstpage:1; lastpage:9; numberofpages:9; journal:JOURNAL FOR IMMUNOTHERAPY OF CANCER; https://hdl.handle.net/11365/1233242Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85114247620; https://jitc.bmj.com/content/9/8/e003188Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404438Test/

    الإتاحة: https://doi.org/10.1136/jitc-2021-003188Test
    https://hdl.handle.net/11365/1233242Test
    https://jitc.bmj.com/content/9/8/e003188Test
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404438Test/

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Adjuvant Nivolumab versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results from CheckMate 238

    المؤلفون: Larkin J., Del Vecchio M., Mandala' M., Gogas H., Fernandez A. M. A., Dalle S., Cowey C. L., Schenker M., Grob J. -J., Chiarion-Sileni V., Marquez-Rodas I., Butler M. O., Di Giacomo A. M., Middleton M. R., Lutzky J., de la Cruz-Merino L., Arenberger P., Atkinson V., Hill A. G., Fecher L. A., Millward M., Nathan P. D., Khushalani N. I., Queirolo P., Ritchings C., Lobo M., Askelson M., Tang H., Dolfi S., Ascierto P. A., Weber J.

    المساهمون: Larkin, J., Del Vecchio, M., Mandala', M., Gogas, H., Fernandez, A. M. A., Dalle, S., Cowey, C. L., Schenker, M., Grob, J. -J., Chiarion-Sileni, V., Marquez-Rodas, I., Butler, M. O., Di Giacomo, A. M., Middleton, M. R., Lutzky, J., de la Cruz-Merino, L., Arenberger, P., Atkinson, V., Hill, A. G., Fecher, L. A., Millward, M., Nathan, P. D., Khushalani, N. I., Queirolo, P., Ritchings, C., Lobo, M., Askelson, M., Tang, H., Dolfi, S., Ascierto, P. A., Weber, J.

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37058595; info:eu-repo/semantics/altIdentifier/wos/WOS:001071142700001; volume:29; issue:17; firstpage:3352; lastpage:3361; numberofpages:10; journal:CLINICAL CANCER RESEARCH; https://hdl.handle.net/11391/1566832Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85166375001

    الإتاحة: https://doi.org/10.1158/1078-0432.CCR-22-3145Test
    https://hdl.handle.net/11391/1566832Test

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    LUMINOS-102: Lerapolturev with and without α-PD- 1 in unresectable α-PD- 1 refractory melanoma

    المؤلفون: Moser, Justin, Wang, Ding, Cowey, C. L, Pisick, Evan, Johnson, Douglas B, Kolodney, Joanna, Mooradian, Meghan J, Pecora, Andrew L, Poklepovic, Andrew S, Tan, Alan, Thomas, Sajeve S, Corum, Daniel, Morris, Shannon R, Kittinger, Hannah, Sorrentino, Jessica, Nichols, William G, Najjar, Yana G

    المصدر: Hematology/Oncology Meeting Abstracts

    وصف الملف: application/pdf

    العلاقة: https://scholarlycommons.henryford.com/hematologyoncology_mtgabstracts/120Test; https://scholarlycommons.henryford.com/context/hematologyoncology_mtgabstracts/article/1120/viewcontent/19th_International_Congress_of_the_Society_for_Melanoma_Research.pdfTest

    الإتاحة: https://scholarlycommons.henryford.com/hematologyoncology_mtgabstracts/120Test
    https://scholarlycommons.henryford.com/context/hematologyoncology_mtgabstracts/article/1120/viewcontent/19th_International_Congress_of_the_Society_for_Melanoma_Research.pdfTest

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Five-year survival with combined nivolumab and ipilimumab in advanced melanoma

    المؤلفون: Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Grob, J. J., Rutkowski, P., Lao, C. D., Cowey, C. L., Schadendorf, D., Wagstaff, J., Dummer, R., Ferrucci, P. F., Smylie, M., Hogg, D., Hill, A., Márquez-Rodas, I., Haanen, J., Guidoboni, M., Maio, M., Schöffski, P., Carlino, M. S., Lebbé, C., McArthur, G., Ascierto, P. A., Daniels, G. A., Long, G. V., Bastholt, L., Rizzo, J. I., Balogh, A., Moshyk, A., Hodi, F. S., Wolchok, J. D.

    المصدر: Larkin , J , Chiarion-Sileni , V , Gonzalez , R , Grob , J J , Rutkowski , P , Lao , C D , Cowey , C L , Schadendorf , D , Wagstaff , J , Dummer , R , Ferrucci , P F , Smylie , M , Hogg , D , Hill , A , Márquez-Rodas , I , Haanen , J , Guidoboni , M , Maio , M , Schöffski , P , Carlino , M S , Lebbé , C , McArthur , G , Ascierto , P A , Daniels ....

    وصف الملف: application/pdf

    العلاقة: https://portal.findresearcher.sdu.dk/da/publications/74cbfdb8-f832-4f2a-91da-1142e9e7701aTest

    الإتاحة: https://doi.org/10.1056/NEJMoa1910836Test
    https://portal.findresearcher.sdu.dk/da/publications/74cbfdb8-f832-4f2a-91da-1142e9e7701aTest
    https://findresearcher.sdu.dk/ws/files/158747018/nejmoa1910836.pdfTest

    View record in BASE

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

    المؤلفون: Wolchok J. D., Chiarion-Sileni V., Gonzalez R., Rutkowski P., Grob J. -J., Cowey C. L., Lao C. D., Wagstaff J., Schadendorf D., Ferrucci P. F., Smylie M., Dummer R., Hill A., Hogg D., Haanen J., Carlino M. S., Bechter O., Maio M., Marquez-Rodas I., Guidoboni M., McArthur G., Lebbe C., Ascierto P. A., Long G. V., Cebon J., Sosman J., Postow M. A., Callahan M. K., Walker D., Rollin L., Bhore R., Hodi F. S., Larkin J.

    المساهمون: Wolchok, J. D., Chiarion-Sileni, V., Gonzalez, R., Rutkowski, P., Grob, J. -J., Cowey, C. L., Lao, C. D., Wagstaff, J., Schadendorf, D., Ferrucci, P. F., Smylie, M., Dummer, R., Hill, A., Hogg, D., Haanen, J., Carlino, M. S., Bechter, O., Maio, M., Marquez-Rodas, I., Guidoboni, M., Mcarthur, G., Lebbe, C., Ascierto, P. A., Long, G. V., Cebon, J., Sosman, J., Postow, M. A., Callahan, M. K., Walker, D., Rollin, L., Bhore, R., Hodi, F. S., Larkin, J.

    مصطلحات موضوعية: Adult, Aged, Antibodies, Monoclonal, Antineoplastic Combined Chemotherapy Protocol, Disease-Free Survival, Double-Blind Method, Human, Ipilimumab, Kaplan-Meier Estimate, Melanoma, Middle Aged, Neoplasm Staging, Nivolumab, Skin Neoplasm, Survival Rate

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28889792; info:eu-repo/semantics/altIdentifier/wos/WOS:000412375000014; volume:377; issue:14; firstpage:1345; lastpage:1356; numberofpages:12; journal:NEW ENGLAND JOURNAL OF MEDICINE; http://hdl.handle.net/11365/1085406Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85030460514

    الإتاحة: https://doi.org/10.1056/NEJMoa1709684Test
    http://hdl.handle.net/11365/1085406Test

    View record in BASE

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma

    المؤلفون: Wolchok J. D., Chiarion-Sileni V., Gonzalez R., Grob J. -J., Rutkowski P., Lao C. D., Cowey C. L., Schadendorf D., Wagstaff J., Dummer R., Ferrucci P. F., Smylie M., Butler M. O., Hill A., Marquez-Rodas I., Haanen J. B. A. G., Guidoboni M., Maio M., Schoffski P., Carlino M. S., Lebbe C., McArthur G., Ascierto P. A., Daniels G. A., Long G. V., Bas T., Ritchings C., Larkin J., Hodi F. S.

    المساهمون: Wolchok, J. D., Chiarion-Sileni, V., Gonzalez, R., Grob, J. -J., Rutkowski, P., Lao, C. D., Cowey, C. L., Schadendorf, D., Wagstaff, J., Dummer, R., Ferrucci, P. F., Smylie, M., Butler, M. O., Hill, A., Marquez-Rodas, I., Haanen, J. B. A. G., Guidoboni, M., Maio, M., Schoffski, P., Carlino, M. S., Lebbe, C., Mcarthur, G., Ascierto, P. A., Daniels, G. A., Long, G. V., Bas, T., Ritchings, C., Larkin, J., Hodi, F. S.

    العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000747787500005; volume:40; issue:2; firstpage:127; lastpage:137; numberofpages:11; journal:JOURNAL OF CLINICAL ONCOLOGY; http://hdl.handle.net/11365/1198507Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85123389119

    الإتاحة: https://doi.org/10.1200/JCO.21.02229Test
    http://hdl.handle.net/11365/1198507Test

    View record in BASE

    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    Adjuvant nivolumab versus ipilimumab in resected stage IIIB–C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial

    المؤلفون: Ascierto P. A., Del Vecchio M., Mandala M., Gogas H., Arance A. M., Dalle S., Cowey C. L., Schenker M., Grob J. -J., Chiarion-Sileni V., Marquez-Rodas I., Butler M. O., Maio M., Middleton M. R., de la Cruz-Merino L., Arenberger P., Atkinson V., Hill A., Fecher L. A., Millward M., Khushalani N. I., Queirolo P., Lobo M., de Pril V., Loffredo J., Larkin J., Weber J.

    المساهمون: Ascierto, P. A., Del Vecchio, M., Mandala, M., Gogas, H., Arance, A. M., Dalle, S., Cowey, C. L., Schenker, M., Grob, J. -J., Chiarion-Sileni, V., Marquez-Rodas, I., Butler, M. O., Maio, M., Middleton, M. R., de la Cruz-Merino, L., Arenberger, P., Atkinson, V., Hill, A., Fecher, L. A., Millward, M., Khushalani, N. I., Queirolo, P., Lobo, M., de Pril, V., Loffredo, J., Larkin, J., Weber, J.

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32961119; info:eu-repo/semantics/altIdentifier/wos/WOS:000584488100049; volume:21; issue:11; firstpage:1465; lastpage:1477; numberofpages:13; journal:THE LANCET ONCOLOGY; http://hdl.handle.net/11365/1136548Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85091951315

    الإتاحة: https://doi.org/10.1016/S1470-2045Test(20)30494-0
    http://hdl.handle.net/11365/1136548Test

    View record in BASE

    أضف إلى المفضلة
  9. 9
    Adjuvant nivolumab (NIVO) vs ipilimumab (IPI) in resected stage III/IV melanoma: 4-y recurrence-free and overall survival (OS) results from CheckMate 238

    المؤلفون: Weber, J. Del Vecchio, M. Mandala, M. Gogas, H. Arance Fernandez, A. M. Dalle, S. Cowey, C. L. Schenker, M. and Grob, J-J. Sileni, V. Chiarion Marquez-Rodas, I. Butler, M. O. Maio, M. Middleton, M. de la Cruz Merino, L. Lobo, M. and de Pril, V. Larkin, J. Ascierto, P. A.

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______2127::8bdbe0770ce4cd23703f322fc858409cTest
    https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3192254Test


    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    VHL Type 2B gene mutation moderates HIF dosage in vitro and in vivo

    المؤلفون: Lee, C M, Hickey, M M, Sanford, C A, McGuire, C G, Cowey, C L, Simon, M C, Rathmell, W K

    المصدر: Oncogene ; volume 28, issue 14, page 1694-1705 ; ISSN 0950-9232 1476-5594

    مصطلحات موضوعية: Cancer Research, Genetics, Molecular Biology

    الإتاحة: https://doi.org/10.1038/onc.2009.12Test
    https://www.nature.com/articles/onc200912.pdfTest
    https://www.nature.com/articles/onc200912Test

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث